Grant: Doctoral Research Award: Canada Graduate Scholarships
McGill University
$105,000.00
Elucidating the factors dictating regulatory T cell function in immune-mediated glomerular diseases.
EF 2019-20
Résumé
Glomerular diseases are a group of autoimmune kidney disorders where the immune system destroys the kidney's glomeruli. Destruction of these structures that filter out wastes from the blood and into the urine leads to the buildup of waste in circulation. Consequently, patients with glomerular diseases often require dialysis for life or kidney transplantation for survival. Currently, there are no specific treatments for glomerular diseases, and instead, broadly immunosuppressive drugs are used to dampen immunity. However, this is associated with significant toxicity including recurrent infections, diabetes and infertility. Accordingly, we aim to better characterize the biological mechanisms involved in glomerular diseases to develop safer and targeted therapeutics.
Regulatory T (Treg) cells are a class of immune cells that dampen inflammation and prevent autoimmunity in all body organs. Researchers recently demonstrated that in order for Treg cells to provide optimal regulation of kidney inflammation, they need to undergo a process referred to as functional adaptation. Here, Treg cells adopt a few characteristics of their inflammatory immune cell counterparts enabling them to migrate to and thrive in locations with heavy inflammation. However, this functional adaptation comes at a cost, as it may cause Treg cells to fully convert into pro-inflammatory, kidney-injuring immune cells. This is referred to as lineage instability. By identifying the factors controlling renal Treg cell functional adaptation and lineage instability, we can envision the development of targeted therapeutics that bolster Treg cell functions in glomerular diseases. Here, we propose to study two factors that we and others have previously observed to control Treg cell function in other inflammatory conditions, namely the IL-1 family of alarmins (IL-1 and IL-33) and branched-chain amino acids (BCAA), in the context of glomerular diseases.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
416915
Name
Al-Aubodah Tho-Alfakar
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Elucidating the factors dictating regulatory T cell function in immune-mediated glomerular diseases.
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Alarmins; Autoimmunity; Cytokines; Effector T Cells; Flow Cytometry; Glomerular Diseases; Immune Cell Culture; Nephrotoxic Nephritis; Plasticity; Regulatory T Cells
Abstract
Glomerular diseases are a group of autoimmune kidney disorders where the immune system destroys the kidney's glomeruli. Destruction of these structures that filter out wastes from the blood and into the urine leads to the buildup of waste in circulation. Consequently, patients with glomerular diseases often require dialysis for life or kidney transplantation for survival. Currently, there are no specific treatments for glomerular diseases, and instead, broadly immunosuppressive drugs are used to dampen immunity. However, this is associated with significant toxicity including recurrent infections, diabetes and infertility. Accordingly, we aim to better characterize the biological mechanisms involved in glomerular diseases to develop safer and targeted therapeutics.
Regulatory T (Treg) cells are a class of immune cells that dampen inflammation and prevent autoimmunity in all body organs. Researchers recently demonstrated that in order for Treg cells to provide optimal regulation of kidney inflammation, they need to undergo a process referred to as functional adaptation. Here, Treg cells adopt a few characteristics of their inflammatory immune cell counterparts enabling them to migrate to and thrive in locations with heavy inflammation. However, this functional adaptation comes at a cost, as it may cause Treg cells to fully convert into pro-inflammatory, kidney-injuring immune cells. This is referred to as lineage instability. By identifying the factors controlling renal Treg cell functional adaptation and lineage instability, we can envision the development of targeted therapeutics that bolster Treg cell functions in glomerular diseases. Here, we propose to study two factors that we and others have previously observed to control Treg cell function in other inflammatory conditions, namely the IL-1 family of alarmins (IL-1 and IL-33) and branched-chain amino acids (BCAA), in the context of glomerular diseases.
Competitiondate
201911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Al-Aubodah, Tho-Alfakar
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~